These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20857899)

  • 1. Reliability of mycophenolic acid monitoring by an enzyme multiplied immunoassay technique.
    Martiny D; Macours P; Cotton F; Thiry P; Gulbis B
    Clin Lab; 2010; 56(7-8):345-53. PubMed ID: 20857899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry.
    Prémaud A; Rousseau A; Picard N; Marquet P
    Ther Drug Monit; 2006 Apr; 28(2):274-7. PubMed ID: 16628144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring.
    Prémaud A; Rousseau A; Le Meur Y; Lachâtre G; Marquet P
    Ther Drug Monit; 2004 Dec; 26(6):609-19. PubMed ID: 15570184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolic acid monitoring in HTX patients: a preliminary report.
    Müller MM; Vogl M; Griesmacher A
    Therapie; 1997; 52(4):341-4. PubMed ID: 9437889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients.
    Kunicki PK; Pawiński T; Boczek A; Waś J; Bodnar-Broniarczyk M
    Ther Drug Monit; 2015 Jun; 37(3):311-8. PubMed ID: 25380305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the bias between liquid chromatography-tandem mass spectrometry and an enzyme multiplied immunoassay technique for the measurement of mycophenolic acid.
    Brown NW; Franklin ME; Einarsdottir EN; Gonde CE; Pires M; Taylor PJ; Tredger JM
    Ther Drug Monit; 2010 Aug; 32(4):420-6. PubMed ID: 20592649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid.
    van Gelder T; Tedesco Silva H; de Fijter JW; Budde K; Kuypers D; Arns W; Soulillou JP; Kanellis J; Zelvys A; Ekberg H; Holzer H; Rostaing L; Mamelok RD
    Transplantation; 2010 Mar; 89(5):595-9. PubMed ID: 20124953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy.
    Weber LT; Shipkova M; Armstrong VW; Wagner N; Schütz E; Mehls O; Zimmerhackl LB; Oellerich M; Tönshoff B
    Clin Chem; 2002 Mar; 48(3):517-25. PubMed ID: 11861442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft outcome and mycophenolic acid trough level monitoring in kidney transplantation.
    Sánchez Fructuoso AI; de la Higuera MA; Garcia-Ledesma P; Giorgi M; Ramos F; Calvo N; Pérez-Flores I; Barrientos A
    Transplant Proc; 2009; 41(6):2102-3. PubMed ID: 19715843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
    Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
    Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
    Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Customized mycophenolate dosing based on measuring inosine-monophosphate dehydrogenase activity significantly improves patients' outcomes after renal transplantation.
    Raggi MC; Siebert SB; Steimer W; Schuster T; Stangl MJ; Abendroth DK
    Transplantation; 2010 Dec; 90(12):1536-41. PubMed ID: 21076373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma.
    Westley IS; Sallustio BC; Morris RG
    Clin Biochem; 2005 Sep; 38(9):824-9. PubMed ID: 15963486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay technique.
    Ansermot N; Fathi M; Veuthey JL; Desmeules J; Rudaz S; Hochstrasser D
    Clin Biochem; 2008 Jul; 41(10-11):910-3. PubMed ID: 18358833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of concordance between EMIT assay and LC-MS/MS for Therapeutic Drug Monitoring of Mycophenolic Acid: Potential increased risk for graft rejection?
    De Nicolò A; Ianniello A; Benagli C; Della Bruna R; Keller F; Antonucci M; D'Avolio A; Cantù M
    J Pharm Biomed Anal; 2020 Aug; 187():113337. PubMed ID: 32442868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of mycophenolic acid in renal transplant recipients.
    Okamoto M; Wakabayashi Y; Higuchi A; Kadotani Y; Ogino S; Ushigome H; Akioka K; Kaihara S; Yoshimura N
    Transplant Proc; 2005 Mar; 37(2):859-60. PubMed ID: 15848556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.